Evaluation of Cardiovascular Risks Among the Participants of the ESC Congress 2025

NCT07613229 | Completed DMC

• 1 other identifier: ESC-CVRISK2025
• Study Type: observational
• Target: 1,366
• Locations: 1 country
• Sites: 1

Brief Summary

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2025 in Madrid.

Conditions

Cardiovascular Risk

Outcome Measures

Primary Outcomes (2)

• Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm in patients without established CVD (primary prevention).

  At baseline

• Second Manifestations or Arterial Disease (SMART) algorithm in patients with established CVD (secondary prevention)

  At baseline

Interventions

blood draw BIOLOGICAL

Blood draw

auscultation PROCEDURE

Auscultation procedure to measure the presence or absence of cardiac murmur and normal or abnormal heart sounds

Questionnaire and Physical Exam BEHAVIORAL

Questionnaire about demographics information, medical history and current CV medication.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All adult attendees (including healthcare professional) attending the ESC Congress 2026 from August 29th to September 1st

You may qualify if:

• All healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2025 from August 29th to September 1st
• Subjects who declare that they are able to understand and give IC in English

You may not qualify if:

• Subjects not willing to provide his/her consent to participate in the study.
• Subjects who are not suitable candidates for blood extraction.

Sponsors & Collaborators

• European Society of Cardiology: lead

Study Sites (1)

Evidenze Health España S.L.U.

Madrid, Spain

Location

MeSH Terms

Interventions

Surveys and Questionnaires; Restraint, Physical; Blood Specimen Collection; Auditory Perception

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Behavior Control; Therapeutics; Immobilization; Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative; Vestibulocochlear Physiological Phenomena; Physiological Phenomena

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 19, 2026
• First Posted: May 29, 2026
• Study Start: August 29, 2025
• Primary Completion: September 1, 2025
• Study Completion: September 1, 2025
• Last Updated: May 29, 2026

Record last verified: 2026-05

Locations

ES (1)